Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

ADCT holding history

ADC Therapeutics SA in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADCT overviewAll 13F holders of ADCTFull Q2 2026 holdings

Shares (Q2 2026)
11,526,710
Value
$12.3M
% of portfolio
0.8%
Quarters held
22
Since Q1 2021
Holdings of ADCT by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202611,526,710$12.3M0.8%−3,943,792−25.5%ReducedHolders
Q1 202615,470,502$58.0M3.8%−196,229−1.3%ReducedHolders
Q4 202515,666,731$55.3M4.1%00.0%UnchangedHolders
Q3 202515,666,731$62.7M6.1%00.0%UnchangedHolders
Q2 202515,666,731$42.0M4.5%00.0%UnchangedHolders
Q1 202515,666,731$22.1M2.1%00.0%UnchangedHolders
Q4 202415,666,731$31.2M2.2%−2,4860.0%ReducedHolders
Q3 202415,669,217$49.4M2.9%+400,000+2.6%AddedHolders
Q2 202415,269,217$48.3M2.9%00.0%UnchangedHolders
Q1 202415,269,217$68.6M2.5%−59,100−0.4%ReducedHolders
Q4 202315,328,317$25.4M0.9%+1,150,272+8.1%AddedHolders
Q3 202314,178,045$12.7M0.6%+128,110+0.9%AddedHolders
Q2 202314,049,935$30.2M1.2%+484,686+3.6%AddedHolders
Q1 202313,565,249$26.5M1.1%+5,974,400+78.7%AddedHolders
Q4 20227,590,849$29.1M1.2%+78,820+1.0%AddedHolders
Q3 20227,512,029$36.2M1.4%00.0%UnchangedHolders
Q2 20227,512,029$59.7M2.3%+79,600+1.1%AddedHolders
Q1 20227,432,429$109.2M3.4%−18,600−0.2%ReducedHolders
Q4 20217,451,029$150.5M3.4%−78,300−1.0%ReducedHolders
Q3 20217,529,329$204.5M3.6%+7,300+0.1%AddedHolders
Q2 20217,522,029$183.2M2.7%+213,611+2.9%AddedHolders
Q1 20217,308,418$178.4M2.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.